Morepen Laboratories Ltd.
NSE: MOREPENLAB | BSE: 500288
₹49.50
₹-1.53
(-3.00%)
As on 19-Jun-2026IST
Market cap
₹2,716 Cr
Revenue (TTM)
₹1,806 Cr
P/E Ratio
28.6
P/B Ratio
2.2
Div. Yield
0.4 %
Quality Score
2/10
Growth Score
6/10
Valuation Score
4/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹95 Cr
-
ROE
11.8 %
-
ROCE
15.5 %
-
Industry P/E
52.5
-
EV/EBITDA
19.3
-
Debt to Equity
0.1
-
Book Value
₹22.7
-
EPS
₹1.3
-
Face value
2
-
Shares outstanding
547,953,699
10 Years Aggregate
CFO
₹187.44 Cr
EBITDA
₹991.12 Cr
Net Profit
₹580.70 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Morepen Lab
| 20.5 | 19.9 | 28.1 | -20.6 | 19.2 | -4.7 | 7.6 |
|
BSE Healthcare
| 10.2 | 1.2 | 12.0 | 10.9 | 24.0 | 14.1 | 12.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Morepen Lab
| -48.1 | 59.2 | 28.3 | -32.7 | 84.7 | 95.5 | -29.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Morepen Lab
|
49.5 | 2,716.2 | 1,805.7 | 95.6 | 4.9 | 5.9 | 28.6 | 2.2 |
| 1,070.3 | 13,119.6 | 2,551.8 | 564.5 | 28.3 | 18.4 | 23.2 | 3.9 | |
| 512.6 | 8,892.7 | 947.3 | 247.8 | 28.5 | 18.9 | 35.9 | 6.5 | |
| 1,315.1 | 13,773.3 | 1,054.9 | 256.3 | 27.8 | 13.7 | 52.8 | 6.8 | |
| 1,776.0 | 33,650.2 | 9,203.5 | 941.3 | 15.4 | 19.6 | 36.4 | 6.8 | |
| 383.6 | 4,175.0 | 165.8 | 46.7 | 37.8 | 16.9 | 89.4 | 14.5 | |
| 17,345.0 | 22,259.3 | 2,023.0 | 364.0 | 23.9 | 20.8 | 61.2 | 11.9 | |
| 979.1 | 4,980.1 | 811.3 | 21.0 | 0.7 | 2.1 | 242.4 | 3.9 | |
| 1,315.0 | 6,056.7 | 649.5 | 121.6 | 23.7 | 13.2 | 52.5 | 6.5 | |
| 268.2 | 7,071.7 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 12.0 |
Shareholding Pattern
View DetailsNews & Analysis
All News
2 min read•By News Desk
About Morepen Lab
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic,... anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides fever X for fever; Pain X for pain; Fiber-X, a sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India. Read more
-
Incorporated
1984
-
Chairman
Sushil Suri
-
Managing Director
Sushil Suri
-
Group
Morepen
-
Headquarters
Solan Dist, Himachal Pradesh
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsReply To Clarification On Price Movement
10-Jun-2026Corporate Action-Board approves Dividend
26-May-2026No News & Announcements are available.
FAQs for Morepen Lab
What is the current share price of Morepen Laboratories Ltd Today?
The share price of Morepen Laboratories Ltd is ₹49.50 (NSE) and ₹49.57 (BSE) as of 19-Jun-2026 IST. Morepen Laboratories Ltd has given a return of 19.24% in the last 3 years.
What is the current PB & PE ratio of Morepen Laboratories Ltd?
The P/E ratio of Morepen Laboratories Ltd is 28.63 times as on 19-Jun-2026, a 45 discount to its peers’ median range of 52.50 times.
The P/B ratio of Morepen Laboratories Ltd is 2.18 times as on 19-Jun-2026, a 44 discount to its peers’ median range of 3.87 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
22.21
|
2.27
|
|
2024
|
22.36
|
2.54
|
|
2023
|
33.94
|
1.74
|
|
2022
|
17.20
|
3.17
|
|
2021
|
14.89
|
3.80
|
What is the 52 Week High and Low of Morepen Laboratories Ltd?
The 52-week high and low of Morepen Laboratories Ltd are Rs 66.40 and Rs 33.05 as of 20-Jun-2026.
What is the market cap of Morepen Laboratories Ltd?
Morepen Laboratories Ltd has a market capitalisation of ₹ 2,716 Cr as on 19-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Morepen Laboratories Ltd?
Before investing in Morepen Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.